PROVIDENCE, R.I. — Brown Surgical Associates Dr. Steven C. Katz explains the incredible advances being made in the treatment of cancer with immunotherapy, particularly in treating certain types of liver and pancreatic cancers.
In this video, he explains how immunotherapy works, and why it offers hope to patients who have tumors that have been deemed inoperable.
Dr. Katz’s overarching career goal is to develop novel immunotherapy treatments for presently incurable liver and pancreas tumors.
Dr. Katz attended New York University School of Medicine, receiving the Alpha Omega Alpha Award for graduating with the top academic average in his class. He then completed his general surgery residency at the New York University Medical Center. Dr. Katz went on to complete fellowships in immunology and surgical oncology at Memorial Sloan-Kettering Cancer Center, where he served as the chief administrative fellow. As a researcher, he has served as the principal investigator for five solid tumor CAR-T trials, including four for liver metastases and one for peritoneal carcinomatosis. Dr. Katz has developed numerous cell therapy products and methods for solid tumor immunotherapy. He has received research grants from numerous societies, the National Institute of Health, and the Department of Defense, in addition to multiple industry partners.